Wealth Enhancement Advisory Services LLC Has $432,000 Stake in Agilon Health, Inc. (NYSE:AGL)

Wealth Enhancement Advisory Services LLC grew its holdings in Agilon Health, Inc. (NYSE:AGL) by 21.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 99,697 shares of the company’s stock after buying an additional 17,866 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Agilon Health were worth $432,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Signaturefd LLC lifted its position in shares of Agilon Health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Humankind Investments LLC acquired a new stake in Agilon Health during the 4th quarter worth approximately $30,000. Raymond James Financial Inc. acquired a new stake in Agilon Health during the 4th quarter worth approximately $33,000. Cerity Partners LLC acquired a new stake in Agilon Health during the 4th quarter worth approximately $34,000. Finally, Huntington National Bank acquired a new stake in Agilon Health during the 4th quarter worth approximately $42,000.

Agilon Health Stock Performance

Shares of AGL opened at $2.40 on Monday. Agilon Health, Inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The business’s fifty day moving average is $2.60 and its 200-day moving average is $3.23. The firm has a market cap of $991.82 million, a price-to-earnings ratio of -4.06 and a beta of 0.16.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same quarter last year, the company posted ($0.02) EPS. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. As a group, research analysts forecast that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

AGL has been the subject of several research reports. JMP Securities reissued a “market perform” rating on shares of Agilon Health in a report on Monday, April 28th. Needham & Company LLC reissued a “hold” rating on shares of Agilon Health in a report on Friday, March 21st. Cowen reissued a “hold” rating on shares of Agilon Health in a report on Tuesday, April 15th. Wells Fargo & Company dropped their price target on Agilon Health from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Tuesday, May 13th. Finally, TD Cowen lifted their price objective on Agilon Health from $3.50 to $6.00 and gave the company a “hold” rating in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.79.

Agilon Health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.